Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid

The Journal of Clinical Investigation
M AraiL W Hoyer

Abstract

Most antibodies to factor VIII have recently been shown to react with discrete regions of the factor VIII light chain (within the C2 domain) and/or the factor VIII heavy chain (within the amino-terminal segment of the A2 domain). The mechanism by which these antibodies, usually designated "factor VIII inhibitors," interfere with factor VIII function has been examined by determining their effect on factor VIII binding to a phospholipid. Factor VIII-phosphatidylserine binding was prevented by all seven factor VIII inhibitors that had strong factor VIII light chain reactivity and reduced by two inhibitors with weak anti-light chain reactivity. None of four inhibitors with heavy chain reactivity prevented factor VIII-phosphatidylserine interaction, though a partial reduction (less than 50%) was noted for the intact IgG preparations. However, when Fab' fragments were substituted, no detectable reduction in factor VIII-phosphatidylserine binding was noted for the anti-heavy chain inhibitors and complete inhibition was retained by the anti-light chain inhibitors. These data suggest that a subset of factor VIII inhibitors, those that bind to light chain determinants, inactivate factor VIII by preventing its effective interaction with p...Continue Reading

References

Nov 1, 1978·The Journal of Clinical Investigation·J Lazarchick, L W Hoyer
Nov 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·C A FulcherT S Zimmerman
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·D ScandellaC A Fulcher
Jul 1, 1986·British Journal of Haematology·G Kemball-Cook, T W Barrowcliffe
Sep 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·W H Kane, E W Davie
Apr 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·D D Pittman, R J Kaufman
Sep 1, 1983·British Journal of Haematology·A YoshiokaA L Bloom
Jun 15, 1983·Thrombosis Research·K BrodénL O Andersson
Nov 22, 1984·Nature·G A VeharD J Capon
Nov 18, 1981·Biochimica Et Biophysica Acta·A LajmanovichG Marguerie
Jan 1, 1995·Human Mutation·S E AntonarakisE G Tuddenham

❮ Previous
Next ❯

Citations

Feb 3, 2009·Clinical Reviews in Allergy & Immunology·Zera TellierBenoît Polack
Jan 23, 2009·Clinical Reviews in Allergy & Immunology·Bharath WootlaSrini V Kaveri
Feb 3, 2009·Clinical Reviews in Allergy & Immunology·Kathleen P Pratt, Arthur R Thompson
Feb 9, 1990·Journal of Immunological Methods·H Borel, Y Borel
Sep 10, 1999·Journal of Chromatography. a·K PockD Josic
Oct 16, 2002·Journal of Immunological Methods·Sébastien Lacroix-DesmazesSrinivas V Kaveri
Mar 29, 2001·Journal of Chromatography. B, Biomedical Sciences and Applications·K PflegerlA Jungbauer
Jul 10, 2003·Autoimmunity Reviews·Jagadeesh BayrySrini V Kaveri
Mar 1, 2002·The New England Journal of Medicine·Sébastien Lacroix-DesmazesSrini V Kaveri
Oct 11, 1991·Proceedings of the National Academy of Sciences of the United States of America·M HiguchiH H Kazazian
Sep 1, 1999·Current Opinion in Hematology·R K Pruthi, W L Nichols
Feb 1, 1995·British Journal of Haematology·A E Morrison, C A Ludlam
Jan 1, 1991·Annals of the New York Academy of Sciences·C K Kasper
Jul 3, 2009·Thrombosis and Haemostasis·John F HealeyPete Lollar
Jun 1, 1994·The Journal of Clinical Investigation·P LollarD Scandella
Mar 4, 2006·International Journal of Hematology·Donna M Dimichele
Mar 4, 2006·International Journal of Hematology·Midori Shima
Oct 13, 2000·Drugs·A Y HoM P Smith
Jun 1, 1992·The American Journal of the Medical Sciences·R B Lalwani, R B Stricker
Dec 27, 2005·Best Practice & Research. Clinical Haematology·Suchitra S Acharya, Donna M DiMichele
Jun 29, 2004·Journal of Thrombosis and Haemostasis : JTH·P Lollar
Jan 31, 2008·Haemophilia : the Official Journal of the World Federation of Hemophilia·S V KaveriS Lacroix-Desmazes
Dec 22, 2006·Journal of Thrombosis and Haemostasis : JTH·J F HealeyP Lollar
Feb 4, 2009·Journal of Thrombosis and Haemostasis : JTH·S L MeeksP Lollar
Sep 22, 2011·British Journal of Haematology·Aurélien LebretonClaude Granier
Oct 13, 2011·British Journal of Haematology·Ankit MahendraSébastien Lacroix-Desmazes
Sep 15, 2012·Journal of Thrombosis and Haemostasis : JTH·Margaret V Ragni
Sep 6, 2008·International Journal of Laboratory Hematology·H Luna-ZáizarA R Jaloma-Cruz
Jul 1, 1992·Thrombosis Research·G Kemball-Cook, T W Barrowcliffe
Nov 10, 2004·Biochimica Et Biophysica Acta·Jialan ShiGary E Gilbert
Feb 28, 2006·Biologicals : Journal of the International Association of Biological Standardization·M StadlerT-E Svae
Nov 26, 2003·Biochimica Et Biophysica Acta·Vivek S PurohitSathyamangalam V Balasubramanian

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.